Morishita Jintan Co., Ltd. (4524.T)

JPY 2065.0

(0.05%)

Total Debt Summary of Morishita Jintan Co., Ltd.

  • Morishita Jintan Co., Ltd.'s latest annual total debt in 2023 was 425 Million JPY , down -20.86% from previous year.
  • Morishita Jintan Co., Ltd.'s latest quarterly total debt in 2024 Q1 was 929 Million JPY , up 118.59% from previous quarter.
  • Morishita Jintan Co., Ltd. reported annual total debt of 537 Million JPY in 2022, down -31.68% from previous year.
  • Morishita Jintan Co., Ltd. reported annual total debt of 786 Million JPY in 2021, down -39.49% from previous year.
  • Morishita Jintan Co., Ltd. reported quarterly total debt of 344 Million JPY for 2023 Q2, down -15.27% from previous quarter.
  • Morishita Jintan Co., Ltd. reported quarterly total debt of 425 Million JPY for 2023 Q4, down -30.44% from previous quarter.

Annual Total Debt Chart of Morishita Jintan Co., Ltd. (2023 - 2019)

Historical Annual Total Debt of Morishita Jintan Co., Ltd. (2023 - 2019)

Year Total Debt Total Debt Growth
2023 425 Million JPY -20.86%
2022 537 Million JPY -31.68%
2021 786 Million JPY -39.49%
2020 1.29 Billion JPY 5.7%
2019 1.22 Billion JPY 0.0%

Peer Total Debt Comparison of Morishita Jintan Co., Ltd.

Name Total Debt Total Debt Difference
Pharma Foods International Co., Ltd. 16.89 Billion JPY 97.484%
Takeda Pharmaceutical Company Limited 4843.75 Billion JPY 99.991%
Sumitomo Pharma Co., Ltd. 418.88 Billion JPY 99.899%
Shionogi & Co., Ltd. 11.62 Billion JPY 96.343%
Wakamoto Pharmaceutical Co.,Ltd. 100.52 Million JPY -322.764%
Nippon Shinyaku Co., Ltd. 2.87 Billion JPY 85.202%
Kaken Pharmaceutical Co., Ltd. 3.85 Billion JPY 88.961%
Eisai Co., Ltd. 206.74 Billion JPY 99.794%
Hisamitsu Pharmaceutical Co., Inc. 2.1 Billion JPY 79.762%
Mochida Pharmaceutical Co., Ltd. 369 Million JPY -15.176%
Fuso Pharmaceutical Industries,Ltd. 12.72 Billion JPY 96.659%
Nippon Chemiphar Co., Ltd. 16.98 Billion JPY 97.497%
Tsumura & Co. 79.69 Billion JPY 99.467%
Kissei Pharmaceutical Co., Ltd. 1.72 Billion JPY 75.391%
Torii Pharmaceutical Co., Ltd. 244 Million JPY -74.18%
Towa Pharmaceutical Co., Ltd. 202.35 Billion JPY 99.79%
Fuji Pharma Co., Ltd. 28.94 Billion JPY 98.532%
Zeria Pharmaceutical Co., Ltd. 47.58 Billion JPY 99.107%
KYORIN Holdings, Inc. 20.94 Billion JPY 97.971%
Taiko Pharmaceutical Co.,Ltd. 3.8 Billion JPY 88.842%
Daito Pharmaceutical Co.,Ltd. 8.71 Billion JPY 95.126%
SymBio Pharmaceuticals Limited - JPY -Infinity%
MedRx Co., Ltd - JPY -Infinity%
Mizuho Medy Co.,Ltd. - JPY -Infinity%
Solasia Pharma K.K. 60 Million JPY -608.333%
Modalis Therapeutics Corporation 412.5 Million JPY -3.03%
ASKA Pharmaceutical Holdings Co.,Ltd. 9.48 Billion JPY 95.519%
Sawai Group Holdings Co., Ltd. 82.89 Billion JPY 99.487%
Cyfuse Biomedical K.K. 913 Million JPY 53.45%
Toho Holdings Co., Ltd. 30.24 Billion JPY 98.595%
Koa Shoji Holdings Co.,Ltd. 2.82 Billion JPY 84.957%